Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients

Helicobacter

Volumn 6, Issue 2, 2001, Pages 136-145

  Yamamoto, Sayuri ^a   Kaneko, Hiroshi ^b   Konagaya, Toshihiro ^c   Mori, Shozaburo ^a   Kotera, Hiroshi ^b   Hayakawa, Toshihiko ^a   Yamaguchi, Chikara ^b   Uruma, Motoaki ^a   Kusugami, Kazuo ^a   Mitsuma, Terunori ^a,c  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Human; Inflammation; Interleukin 8; Peptic ulcer; Somatostatin

Indexed keywords

CLARITHROMYCIN; INTERLEUKIN 8; OMEPRAZOLE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; MOLECULAR INTERACTION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ULCER;

ADULT; AGED; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC JUICE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PEPTIC ULCER; PYLORIC ANTRUM; SOMATOSTATIN; STOMACH; STOMACH ULCER;

HELICOBACTER PYLORI;

EID: 0034961876     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2001.00020.x     Document Type: Article

References (43)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
2. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
3. Campylobacter pylori and duodenal ulcers: The gastrin link
4. Gastric secretion
5. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentration of human stomach
6. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease
7. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects
8. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa
9. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children
10. Effect of Helicobacter pylori eradication on antral gastrin-, somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations
11. Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations
12. Helicobacter pylori infection is associated with low antral somatostatin content in young adults
13. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa
14. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis
15. Immune and inflammatory responses to Helicobacter pylori infection
16. Tumor necrosis factor alpha stimulates gastrin release from canine and human antral G cells: Possible mechanism of the Helicobacter pylori-gastrin link
17. Mononuclear cells and cytokines stimulate gastrin release from canine antral cells in primary culture
18. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells
19. Cost-effectiveness of the treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer
20. Current FDA-approved treatments for Helicobacter pylori and the FDA approval process
21. The influence of drug dosage on Helicobacter pylori eradication: A cost-effective analysis
22. The Participants in the International Workshop on the Histopathology of Gastritis Houston 1994. Classification and grading of gastritis. The updated Sydney system
23. Acute inflammation of the proliferative zone of gastric musosa in Helicobacter pylori gastritis
24. A simplification of the protein assay method of Lowry et al. Which is more generally applicable
25. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients
26. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients
27. Omeplazole plus amoxycillin for cure of Helicobacter pylori infection
28. Factors influencing the eradication of Helicobacter pylori with triple therapy
29. Somatostatin and the gastrointestinal tract
30. Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans
31. The somatostatin-gastirn link of Helicobacter pylori infection
32. Helicobacter pylori, acid and gastrin
33. Cytokine gene expression in Helicobacter pylori associated antral gastritis
34. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication
35. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer
36. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori
37. Effect of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics
38. Effect of transforming growth factor α and interleukin 8 on somatostatin release from canine fundic D cells
39. Relationship between interleukin-8 levels and myeloperoxidase activity in human gastric mucosa
40. Negative correlation between somatostatin levels and interleukin-8 activity in gastric antral mucosa
41. Neutrophil elastase in respiratory epithelial lining fluid of individuals in a human bronchial epithelial cell line
42. Modulation of cytokine production in activated human monocytes by somatostatin
43. Mouse model of Helicobacter pylori infection: Studies of gastric function and ulcer healing